Bio-Techne Form 4/A Filed for Aug. 15 by William Geist

TETRA Technologies Reports Quarterly Results Through September 30 M impact | EQUITY | Nov 02, 2026, 11:39 PM UTC

Samsung Biologics Signs $324.8 Million Drug Manufacturing Contract Samsung Biologics signed a drug manufacturing contract worth USD 324.8 million. M impact | EQUITY | Nov 02, 2026, 11:37 PM UTC

Ero Copper Reports Quarterly Results for Quarter Ended September 30 M impact | EQUITY | Nov 02, 2026, 11:36 PM UTC

PLDT Auditor SGV Resigns Over Independence Concerns PLDT’s auditor, SyCip Gorres Velayo (SGV), resigned, citing a lack of independence. M impact | EQUITY | Nov 02, 2026, 11:34 PM UTC

Argentine Stocks Fall for Sixth Straight Session as Country Risk Tops 800 Argentine shares fell for a sixth consecutive session, country risk exceeded 800 points and the central bank did not buy reserves. M impact | EQUITY | Nov 02, 2026, 11:34 PM UTC

Axsome Therapeutics Shares Hit 52-Week Low as Much as 15% Axsome shares fell as much as 15% on Monday as investors focused on Auvelity launch pacing in Alzheimer’s disease agitation, despite the company’s strong third-quarter report. M impact | EQUITY | Nov 02, 2026, 11:32 PM UTC

Bio-Techne Form 4/A Filed for Aug. 15 by William Geist

Related stories